Upgrading Public Health Programs for Human Papillomavirus Prevention and Control is Possible in Low- and Middle-income Countries

This publication has 22 references indexed in Scilit:

• Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
  BMJ, 2012
• Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial
  The Lancet, 2011
• Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries
  Bulletin of the World Health Organization, 2011
• Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
  JNCI Journal of the National Cancer Institute, 2011
• Advancing Cervical Cancer Prevention Initiatives in Resource-Constrained Settings: Insights from the Cervical Cancer Prevention Program in Zambia
  PLoS Medicine, 2011
• Worldwide burden of cervical cancer in 2008
  Annals of Oncology, 2011
• Cervical cancer screening with naked-eye visual inspection in Colombia
  International Journal of Gynecology & Obstetrics, 2010
• The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
  Archives of Medical Research, 2009
• HPV Screening for Cervical Cancer in Rural India
  New England Journal of Medicine, 2009
• A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China
  The Lancet Oncology, 2008